Samantha McLemore - Patient Capital Management
Holding/activity history for Royalty Pharma plc (RPRX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 2,041,195 | 2.84 | Add 43.30% | 0.86 | $28.29 |
| 2024 Q2 | 1,424,390 | 1.99 | Add 0.32% | 0.01 | $26.37 |
| 2024 Q1 | 1,419,818 | 2.10 | Add 13.15% | 0.24 | $30.37 |
| 2023 Q4 | 1,254,780 | 1.87 | Buy | 1.87 | $28.09 |